MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates (PWML)
MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study
Sponsor: Baoji Central Hospital
A observational or N/A phase clinical study on Amblyopia and Brain Damage, Chronic, this trial is ongoing. The trial is conducted by Baoji Central Hospital and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jul 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jul 2018 — Jul 2020 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baoji Central Hospital
- Children's Hospital of Fudan University
- First Affiliated Hospital Xi'an Jiaotong University
- General Hospital of Ningxia Medical University
- Hainan People's Hospital
- Second Affiliated Hospital of Wenzhou Medical University
- Shaanxi Provincial People's Hospital
- Shengjing Hospital
- Shenzhen Children's Hospital
- Xijing Hospital
- Zunyi Medical College
For direct contact, visit the study record on ClinicalTrials.gov .